Our results clearly showed that the p53LCs failed to transcriptionally activate p53 target genes, such as MDM2 and p21, or inhibit proliferation and survival of cancer cells (Figure 1; Supplementary Figure S2). This evidence concerns the gene MDM2 and cancer.